XML 81 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements (Tables)
3 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of assets measured at fair value on a recurring basis
The assets measured at fair value on a recurring basis were as follows: 
(in millions)
 
Level 1
 
Level 2
 
Level 3
 
NAV as a
Practical
Expedient
 
Total
as of December 31, 2019
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Equity securities, at fair value
 
 
 
 
 
 
 
 
 
 
Sponsored funds
 
$
794.9

 
$
10.6

 
$

 
$
69.2

 
$
874.7

Other equity securities
 
24.2

 
0.5

 
10.9

 
26.1

 
61.7

Debt securities
 
 
 
 
 
 
 
 
 

Trading
 

 
29.6

 
17.9

 

 
47.5

Available-for-sale
 

 
2.0

 

 

 
2.0

Life settlement contracts
 

 

 
11.4

 

 
11.4

Total Assets Measured at Fair Value
 
$
819.1

 
$
42.7

 
$
40.2


$
95.3

 
$
997.3

(in millions)
 
Level 1
 
Level 2
 
Level 3
 
NAV as a
Practical
Expedient
 
Total
as of September 30, 2019
 
 
 
 
 
Assets
 
 
 
 
 
 
 
 
 
 
Equity securities, at fair value
 
 
 
 
 
 
 
 
 
 
Sponsored funds
 
$
397.0

 
$

 
$

 
$
69.4

 
$
466.4

Other equity securities
 
22.6

 
3.2

 
0.8

 
37.0

 
63.6

Debt securities
 
 
 
 
 
 
 
 
 
 
Trading
 

 
24.4

 
19.8

 

 
44.2

Available-for-sale
 

 
4.0

 

 

 
4.0

Life settlement contracts
 

 

 
11.5

 

 
11.5

Total Assets Measured at Fair Value
 
$
419.6

 
$
31.6

 
$
32.1

 
$
106.4

 
$
589.7


Schedule of changes in Level 3 assets and liability
Changes in the Level 3 assets and liability were as follows: 
 
 
2019
 
2018
(in millions)
 
Investments
 
Investments
 
Contingent
Consideration
Liability
for the three months ended December 31,
 
 
 
Balance at beginning of period
 
$
32.1

 
$
32.6

 
$
(38.7
)
Total realized and unrealized gains (losses)
 
 
 
 
 
 
Included in investment and other income (losses), net
 
(0.3
)
 
2.8

 

Included in general, administrative and other expense
 

 

 
(1.3
)
Purchases
 
12.6

 

 

Sales
 
(1.5
)
 
(4.3
)
 

Settlements
 
(2.7
)
 

 

Transfers out of Level 3
 

 
(2.1
)
 

Balance at End of Period
 
$
40.2

 
$
29.0

 
$
(40.0
)
Change in unrealized gains (losses) included in net income relating to assets and liability held at end of period
 
$
(0.3
)
 
$
2.8

 
$
(1.3
)

Schedule of valuation techniques and significant unobservable inputs used in level 3 fair value measurements
Valuation techniques and significant unobservable inputs used in the Level 3 fair value measurements were as follows:
(in millions)
 
 
 
 
 
 
 
 
as of December 31, 2019
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Range (Weighted Average1)
Equity securities, at fair value
 
$
10.9

 
Market pricing
 
Private sale pricing
 
$1,000 per share
 
 
 
 
 
 
 
 
 
Debt securities, trading
 
17.9

 
Discounted cash flow
 
Discount rate
 
1.5%–15.5% (6.8%)
Risk premium
 
2.0%–6.1% (3.8%)
 
 
 
 
 
 
 
 
 
Life settlement contracts
 
11.4

 
Discounted cash flow
 
Life expectancy
 
19–105 months (55)
Discount rate
 
10.0%–20.0% (13.4%)

(in millions)
 
 
 
 
 
 
 
 
as of September 30, 2019
 
Fair Value
 
Valuation Technique
 
Significant Unobservable Inputs
 
Range (Weighted Average1)
Debt securities, trading
 
$
19.8

 
Discounted cash flow
 
Discount rate
 
2.7%–13.3% (6.7%)
Risk premium
 
2.0%–6.1% (4.2%)
 
 
 
 
 
 
 
 
 
Life settlement contracts
 
11.5

 
Discounted cash flow
 
Life expectancy
 
19–107 months (57)
Discount rate
 
8.0%–20.0% (13.2%)

Schedule of financial instruments not measured at fair value
Financial instruments that were not measured at fair value were as follows:
(in millions)
 
Fair Value
Level
 
December 31, 2019
 
September 30, 2019
 
 
Carrying
Value
 
Estimated
Fair Value
 
Carrying
Value
 
Estimated
Fair Value
Financial Assets
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
1
 
$
5,817.3

 
$
5,817.3

 
$
5,803.4

 
$
5,803.4

Other investments
 
 
 
 
 
 
 
 
 
 
Time deposits
 
2
 
16.8

 
16.8

 
15.4

 
15.4

Equity securities
 
3
 
18.9

 
20.7

 
17.3

 
19.2

 
 
 
 
 
 
 
 
 
 
 
Financial Liability
 
 
 
 
 
 
 
 
 
 
Debt
 
2
 
$
697.0

 
$
720.2

 
$
696.9

 
$
718.7